<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>59</patient-age><report-id>US-PFIZER INC-2013032803</report-id><gender>female</gender><reactions><reaction>gets very weepy and cried real easy</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Pristiq</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CELEBREX</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Depression</indication><indication>Arthritis</indication><indication>General body pain</indication><indication>Pain</indication></indications><patient-age>59</patient-age><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254130_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151553</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2013032803</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="2">No</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-24</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-24</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2013032803</companynumb>
		<medicallyconfirm>2</medicallyconfirm>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientonsetage>59</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientweight>67</patientweight>
			<patientheight>160</patientheight>
			<patientsex code="2">Female</patientsex>
			<resultstestsprocedures>Blood work for diabetes (2012): normal</resultstestsprocedures>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Depression</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking desvenlafaxine</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Diabetes</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking unspecified medication</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Arthritis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking celecoxib</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>General body pain</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking celecoxib</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pain</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking celecoxib</patientmedicalcomment>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>gets very weepy and cried real easy</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Crying</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Crying</reactionmeddrapt>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Pristiq</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>21-992</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>50</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>50 mg, 1x/day</drugdosagetext>
				<drugdosageform normalized="prolonged-release tablet">Prolonged-release tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Depression</drugindication>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>DESVENLAFAXINE SUCCINATE MONOHYDRATE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Crying</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Crying</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CELEBREX</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Arthritis</drugindication>
				<activesubstance>
					<activesubstancename>CELECOXIB</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CELEBREX</medicinalproduct>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>General body pain</drugindication>
				<activesubstance>
					<activesubstancename>CELECOXIB</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CELEBREX</medicinalproduct>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Pain</drugindication>
				<activesubstance>
					<activesubstancename>CELECOXIB</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from a Non Clinical study program Pfizer Helpful Answers from a contactable consumer. A 59-year old <Semaphore x="2699001" class="Race" value="White" score="1.00" ID="C41261">White female </Semaphore>consumer started taking <Semaphore x="445837" class="Medicine - Desvenlafaxine - Frequency" value="oral" score="0.49" ID=""><Semaphore x="445807" class="Medicine - Desvenlafaxine - Dose" value="50mg" score="0.49" ID=""><Semaphore x="445868" class="Medicine" value="Desvenlafaxine" score="0.97" ID="282218">desvenlafaxine </Semaphore>(<Semaphore x="1085419" class="Medicine - Pristiq - Dose" value="50mg" score="0.49" ID=""><Semaphore x="1085448" class="Medicine" value="Pristiq" score="0.49" ID="281190">PRISTIQ</Semaphore>) <Semaphore x="1914726485327874" class="Medicine - Desvenlafaxine - Dose" value="50mg" score="0.49" ID="">50mg </Semaphore></Semaphore></Semaphore>
     <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore></Semaphore>tablet once a day for <Semaphore x="1842410" class="Procedure" value="Depression After Stopping Dexamethasone" score="1.00" ID="C113456">depression </Semaphore>on an unknown date. Relevant medical history included <Semaphore x="1547427" class="Disease or Finding" value="Arthritis" score="1.00" ID="C2883">arthritis</Semaphore>, <Semaphore x="1609977" class="Disease or Finding" value="Bodily Pain" score="1.00" ID="C114901">body <Semaphore x="1412208" class="Disease or Finding" value="Ache" score="1.00" ID="C86024">ache</Semaphore>, <Semaphore x="3167117" class="MedDRA LLT" value="Pain" score="1.00" ID="10033371">pain</Semaphore></Semaphore>, <Semaphore x="1842410" class="Procedure" value="Depression After Stopping Dexamethasone" score="1.00" ID="C113456">depression </Semaphore>and <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes </Semaphore>which were ongoing during the events. Relevant concomitant medications included <Semaphore x="317651" class="Medicine" value="celecoxib" score="0.49" ID="232646">celecoxib </Semaphore>(<Semaphore x="317614" class="Medicine" value="CeleBREX" score="0.49" ID="247835">CELEBREX</Semaphore>) for <Semaphore x="1547427" class="Disease or Finding" value="Arthritis" score="1.00" ID="C2883">arthritis</Semaphore>, <Semaphore x="1609977" class="Disease or Finding" value="Bodily Pain" score="1.00" ID="C114901">body <Semaphore x="1412208" class="Disease or Finding" value="Ache" score="1.00" ID="C86024">ache </Semaphore>and <Semaphore x="3167117" class="MedDRA LLT" value="Pain" score="1.00" ID="10033371">pain </Semaphore></Semaphore>and unspecified medication for <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes </Semaphore>and she was taking the concomitant medications during the event. She stopped taking <Semaphore x="445868" class="Medicine" value="Desvenlafaxine" score="0.97" ID="282218">desvenlafaxine </Semaphore>as she could not afford. After stopping <Semaphore x="445868" class="Medicine" value="Desvenlafaxine" score="0.97" ID="282218">desvenlafaxine </Semaphore>she "got very <Semaphore x="2886361" class="MedDRA LLT" value="Crying" score="1.00" ID="10011469">weepy</Semaphore>" and "<Semaphore x="1823070" class="Procedure" value="Cryo-Electron Microscopy" score="1.00" ID="C18113">cried </Semaphore>real easy". She restarted taking <Semaphore x="445868" class="Medicine" value="Desvenlafaxine" score="0.97" ID="282218">desvenlafaxine </Semaphore><Semaphore x="1914726485327873" class="Medicine - Desvenlafaxine - Dose" value="50 mg" score="0.49" ID="">50 mg </Semaphore><Semaphore x="1914855334346753" class="Medicine - Desvenlafaxine - Frequency" value="once" score="0.49" ID="">once </Semaphore>a day. Relevant <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">lab </Semaphore>data included <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore>work for <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes </Semaphore>done in 2012 and <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">results </Semaphore>were normal. At the time of the report she was taking <Semaphore x="445868" class="Medicine" value="Desvenlafaxine" score="0.97" ID="282218">desvenlafaxine</Semaphore>. She had recovered from the above mentioned events on an unknown date.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>